Who invested in PatientPing

3 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$101Mraised across 3 rounds since 2015, from 4 sources

$9.6MVenture$32MSeries B$60MSeries C

Latest round: Series C, $60MJun 2020
Step-upi: 1.9×
Investors: 7 (2 led)

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162017201820192020

$9.6MVenture$32MSeries B$60MSeries C

First round: Venture, $9.6M
Biggest round: $60M
Usual gap between rounds: 3.5 years

The rounds

Jun 2020
Series C$60M3 returning
Source recorded
Dec 2016
Series B$32M2 new3 returning
Reported by FinSMEs and 1 otherSEC filing: $32M sold, first sale Nov 2016
Nov 2015
Venture$9.6M5 new
From a historical funding recordSEC filing: $9.7M sold, first sale May 2015

Founders and team

From PatientPing's own website and the SEC filings it signed: 6 on the team.

Jeff SmithChief Executive Officer
Darren MooreChief Legal Officer
Erik MooreChief Technology Officer
Nazir RostomChief Operations and Financial Officer
Ross ArmstrongChief Commercial Officer
Jay DesaiExecutive Officer, Directori

On the board, as filediJon LimKrishna Yeshwant

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2015Series B2016Series C2020

F-Prime CapitalLeerink Transformation PartnersLCarl Byers

Everyone who backed them

SV AngelVC firm3rounds

Andreessen HorowitzVC firm2rounds, led 1

Google VenturesCorporate VC2rounds

First Round CapitalVC firm2rounds

F-Prime CapitalVC firm2rounds

Leerink Transformation PartnersVC firm1round, led 1

Carl ByersAngel1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists PatientPing as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.